Fig. 3

Histogram showing the proportion of patients with ≥ 5%, ≥ 10%, ≥ 15% and ≥ 20% weight loss following 12 months of GLP1-RA treatment overall and stratified by analog (n = 40). GLP1-RA, glucagon-like peptide-1 receptor agonist